Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study

Basit Öğe Kaydı
dc.authorid0000-0003-1864-0316
dc.authorid0000-0003-3312-8476
dc.authorwosidBasturk, Abdulkadir/B-1962-2018
dc.authorwosidBERBER, Ilhami/ABI-6231-2020
dc.authorwosidÖzcan, Mehmet Ali/Q-1897-2019
dc.authorwosidOzkocaman, Vildan/AAH-1854-2021
dc.contributor.authorTombak, Anıl
dc.contributor.authorPepedil Tanrıkulu, Funda
dc.contributor.authorDurusoy, Salih Sertaç
dc.contributor.authorGürkan, Emel
dc.contributor.authorKaya, Emin
dc.contributor.authorÜmit, Elif Gülsüm
dc.contributor.authorFerhanoğlu, Burhan
dc.contributor.authorAkpınar, Seval
dc.date.accessioned2022-05-11T14:39:57Z
dc.date.available2022-05-11T14:39:57Z
dc.date.issued2019
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) -- DEC 07-10, 2019 -- Orlando, FL
dc.description.abstract[No Abstract Available]
dc.description.sponsorshipAmer Soc Hematol
dc.identifier.doi10.1182/blood-2019-126402
dc.identifier.issn0006-4971
dc.identifier.issn1528-0020
dc.identifier.urihttps://doi.org/10.1182/blood-2019-126402
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8810
dc.identifier.volume134
dc.identifier.wosWOS:000577164606194
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.institutionauthorAkpınar, Seval
dc.language.isoen
dc.publisherAmer Soc Hematology
dc.relation.ispartofBlood
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleEfficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu